We are live on ! Find out more
NRD

Nebula Research & Development Portfolio holdings

AUM $1.17B
1-Year Est. Return 15.19%
This Fund
S&P 500
This Quarter Est. Return
-6.2%
1 Year Est. Return
+15.19%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$190M
AUM Growth
+$57.8M
Cap. Flow
+$73.8M
Cap. Flow %
38.92%
Top 10 Hldgs %
5.1%
Holding
699
New
375
Increased
49
Reduced
49
Closed
226

Sector Composition

Rank Sector Weight
1 Technology 17.57%
2 Industrials 16.5%
3 Healthcare 14.54%
4 Financials 10.48%
5 Consumer Discretionary 10.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RAMP icon
226
LiveRamp
RAMP
$2.3B
$353K 0.19%
+12,229
New +$361K
MASI
227
DELISTED
Masimo
MASI
$352K 0.19%
+4,014
New +$467K
TNK icon
228
Teekay Tankers
TNK
$2.63B
$352K 0.19%
+8,452
New +$345K
FC icon
229
Franklin Covey
FC
$245M
$351K 0.19%
+8,189
New +$363K
TMO icon
230
Thermo Fisher Scientific
TMO
$208B
$350K 0.18%
+692
New +$369K
FATE icon
231
Fate Therapeutics
FATE
$283M
$347K 0.18%
163,617
+121,025
+284% +$401K
RTX icon
232
RTX Corp
RTX
$294B
$346K 0.18%
+4,808
New +$412K
HUBG icon
233
HUB Group
HUBG
$2.93B
$344K 0.18%
8,772
+1,814
+26% +$74.4K
FVRR icon
234
Fiverr
FVRR
$398M
$344K 0.18%
14,047
-10,109
-42% -$285K
INTA icon
235
Intapp
INTA
$2.27B
$341K 0.18%
10,172
-3,847
-27% -$140K
VRE
236
DELISTED
Veris Residential
VRE
$338K 0.18%
+20,496
New +$361K
EIX icon
237
Edison International
EIX
$30.3B
$338K 0.18%
+5,341
New +$372K
AMK
238
DELISTED
AssetMark Financial Holdings, Inc.
AMK
$337K 0.18%
+13,441
New +$383K
RSKD icon
239
Riskified
RSKD
$702M
$337K 0.18%
+75,181
New +$346K
ITCI
240
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$337K 0.18%
+6,465
New +$377K
RGEN icon
241
Repligen
RGEN
$7.39B
$336K 0.18%
+2,113
New +$345K
ROCK icon
242
Gibraltar Industries
ROCK
$1.36B
$335K 0.18%
+4,967
New +$340K
CVI icon
243
CVR Energy
CVI
$3.43B
$335K 0.18%
+9,852
New +$337K
DT icon
244
Dynatrace
DT
$12.7B
$334K 0.18%
+7,155
New +$351K
CNXC icon
245
Concentrix
CNXC
$1.5B
$334K 0.18%
4,168
+327
+9% +$25.7K
PLAB icon
246
Photronics
PLAB
$1.76B
$334K 0.18%
16,504
+3,629
+28% +$84.8K
MCY icon
247
Mercury Insurance
MCY
$6.01B
$333K 0.18%
+11,884
New +$350K
JBSS icon
248
John B. Sanfilippo & Son
JBSS
$978M
$328K 0.17%
+3,324
New +$350K
EEFT icon
249
Euronet Worldwide
EEFT
$3.01B
$328K 0.17%
+4,137
New +$384K
PLTK icon
250
Playtika
PLTK
$1.48B
$327K 0.17%
+33,996
New +$364K

Similar funds

Nebula Research & Development's Q3 2023 Portfolio in Review

As of Q3 2023, Nebula Research & Development held 699 positions worth $190M, up 44% from $132M the previous quarter. Its ten largest holdings account for 5.1% of the portfolio.

Nebula Research & Development deployed $73.8M of net new capital in Q3 2023, opening 375 new positions and adding to 49 existing holdings. Its largest new stake was Louisiana-Pacific: 17,424 shares worth $963K.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was NexGen Energy, an estimated $632K trimmed.

  • Nebula Research & Development's largest Q3 2023 buy was Louisiana-Pacific: 17,424 shares worth $963K.
  • Nebula Research & Development added most to Hanesbrands in Q3 2023, an estimated $1.04M increase.
  • Nebula Research & Development's biggest Q3 2023 reduction was NexGen Energy, cutting an estimated $632K.
  • Nebula Research & Development fully exited Realty Income in Q3 2023, selling an estimated $636K.
  • Nebula Research & Development's ten largest holdings make up 5.1% of its $190M portfolio in Q3 2023.
  • Nebula Research & Development opened 375 new positions and closed 226 in Q3 2023.
  • Nebula Research & Development's portfolio value rose 44% quarter-over-quarter to $190M.

Based on Nebula Research & Development's 13F filing for Q3 2023, filed 14 Nov 2023.